 Exact Sciences Corporation NASDAQ: EXAS says that Pfizer Inc NYSE: PFE will no longer join the Company from November 30 to promote its Cologuard colorectal cancer screening test to health care providers. The decision follows an amendment to a co-promotion agreement signed by the two companies. 